Evidence map›Paper›PMID 32296738›Full record

ArticleCurrent opinion in biomedical engineering2019

Single-molecule investigations of T-cell activation.

Li Kaitao, Rittase William, Yuan Zhou, Zhu Cheng

Open access · greenAbstract read
In one paragraph

Article in Current opinion in biomedical engineering, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Li KaitaoWallace H. Coulter Department of Biomedical Engineering.
Rittase WilliamWallace H. Coulter Department of Biomedical Engineering.
Yuan ZhouGeorge W. Woodruff School of Mechanical Engineering.
Zhu ChengWallace H. Coulter Department of Biomedical Engineering.
Georgia Institute of Technology · USThe Wallace H. Coulter Department of Biomedical Engineering · US

Funding

Mechanisms of impaired T-cell mechanosensing of melanoma antigensU01CA214354 · NCI · GEORGIA INSTITUTE OF TECHNOLOGY · PI KROGSGAARD, MICHELLE, ZHU, CHENG · 2017 to 2021
$3.9M
Exploiting the Mechanobiology of PD-1 for Cancer ImmunotherapyU01CA250040 · NCI · GEORGIA INSTITUTE OF TECHNOLOGY · PI ZHU, CHENG · 2020 to 2024
$3.5M
T cell compartmentalization and antiviral responseR01AI124680 · NIAID · EMORY UNIVERSITY · PI GRAKOUI, ARASH, ZHU, CHENG · 2016 to 2020
$3.2M
DNA origami based molecular probes for quantitative study on TCR/CD8 binding with pMHCsR21AI135753 · NIAID · EMORY UNIVERSITY · PI KE, YONGGANG, ZHU, CHENG · 2018 to 2019
$428k
NCI NIH HHS U01 CA214354NCI NIH HHS U01 CA250040NIAID NIH HHS R01 AI124680NIAID NIH HHS R21 AI135753
6 · The paper itself

Abstract

T-cell activation is the central event governing its development, differentiation, and effector functions. T-cell activation is initiated by the direct physical interaction of the T cell antigen receptor (TCR) with cognate peptide presented by the major histocompatibility complex (pMHC) molecule expressed on the antigen presenting cell (APC) surface. Since the identification of TCR as the only receptor for antigen on T cells three decades ago, studies have elucidated the major molecular players and signaling events responding to TCR stimulation. However, the question of how the physical event of pMHC binding is converted across the membrane into chemical events to initiate signal transduction remains elusive. Here we review recent investigations of T-cell activation using single-molecule force and fluorescence techniques that shed new light on this key question.

Identifiers

PMID32296738
PMCPMC7158867
OpenAlexW2988094906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.